Business Of Biotech

241 Folgen

1. Off-The-Shelf CAR T-Cell Therapy with John McKearn, Ph.D.

   Vom: 26.10.2020
2. CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

   Vom: 13.10.2020
3. 010: Gap Analysis With Dr. Pablo Valenzuela & Cristián Hernández-Cuevas

   Vom: 28.9.2020
4. 009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle

   Vom: 21.9.2020
5. 008: Commitment To GMP With Dr. Shabbir Anik

   Vom: 14.9.2020
6. 007: Quality Data For FDA Submissions With Dr. Robert Hariri

   Vom: 8.9.2020
7. Summer Sessions 8: Dr. Gaurav Shah, Rocket's Chief Gene Therapist & Virtuoso

   Vom: 31.8.2020
8. Summer Sessions 7: Dr. Randall Schatzman & The New Fundraising Norm

   Vom: 24.8.2020
9. Summer Sessions 6: Alexis Peyroles On Myeloid Cells, Transplants, & Immuno-Oncology Inspiration

   Vom: 17.8.2020
10. Summer Sessions 5: Dr. Christopher Anzalone Takes RNAi Beyond The Liver

    Vom: 10.8.2020
11. Summer Sessions 4: Dr. Loretta Itri On Taking ADCs Across The Finish Line

    Vom: 3.8.2020
12. Summer Sessions 3: Jeff Wolf Builds Heat Bio On Its Therapeutic Platform

    Vom: 27.7.2020
13. Summer Sessions 2: Dr. Paul Wotton Solves A COVID-19 Workforce Crisis

    Vom: 20.7.2020
14. Summer Sessions 1: Ivor Macleod brings big-league finance experience to an emerging biotech

    Vom: 13.7.2020
15. 006: Leaving The Incubator With Kavitha Iyer Rodrigues

    Vom: 29.6.2020
16. 005: Building A Biotech All-Star Team With Vivek Ramaswamy

    Vom: 15.6.2020
17. 004: Finding Funding In Volatile Times With Dr. Ben Zeskind

    Vom: 1.6.2020
18. 003: Building The Biopharma Pitch With Leslie Williams

    Vom: 18.5.2020
19. 002: The Biopharma Exit Strategy With Dr. Francois Nader

    Vom: 4.5.2020
20. 001: The Business Of Biotech: Allan Shaw

    Vom: 20.4.2020